| | |
Progress of small molecules for targeted protein degradation: PROTACs and other technologies | Drug Development Research | 2023 |
Novel strategies and promising opportunities for targeted protein degradation: An innovative therapeutic approach to overcome cancer resistance | Pharmacology and Therapeutics | 2023 |
Targeted protein degrader development for cancer: advances, challenges, and opportunities | Trends in Pharmacological Sciences | 2023 |
PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy | Molecular Cancer | 2023 |
Delivering on the promise of protein degraders | Nature Reviews Drug Discovery | 2023 |
PROTAC targeted protein degraders: the past is prologue | Nature Reviews Drug Discovery | 2022 |
Targeted protein degradation: mechanisms, strategies and application | Signal Transduction and Targeted Therapy | 2022 |
Key Considerations in Targeted Protein Degradation Drug Discovery and Development | Frontiers in Chemistry | 2022 |
Targeted Protein Degradation: Clinical Advances in the Field of Oncology | International Journal of Molecular Sciences | 2022 |
Targeted protein degradation: Emerging concepts and protein state-specific targeting principles | Current Opinion in Chemical Biology | 2022 |
PROTACs: past, present and future | Chemical Society Reviews | 2022 |
Protein degradation technology: a strategic paradigm shift in drug discovery | Journal of Hematology and Oncology | 2021 |
Small-Molecule Approaches to Targeted Protein Degradation | Annual Reviews of Cancer Biology | 2021 |
Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery | Journal of Medicinal Chemistry | 2021 |
Recent Developments in PROTAC-Mediated Protein Degradation: From Bench to Clinic | ChemBioChem | 2021 |
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs | Journal of Biological Chemistry | 2021 |
The PROTACtable genome | Nature Reviews Drug Discovery | 2021 |
PROTAC Technology: Opportunities and Challenges | ACS Med. Chem. Lett. | 2020 |
PROTACs: An Emerging Therapeutic Modality in Precision Medicine | Cell Chemical Biology | 2020 |
Targeted protein degradation: expanding the toolbox | Nature Reviews Drug Discovery | 2019 |
Targeted Protein Degradation: from Chemical Biology to Drug Discovery | Cell Chemical Biology | 2017 |